Korean J Gastroenterol.  2020 Mar;75(3):117-119. 10.4166/kjg.2020.75.3.117.

Sarcopenia as a Risk Factor for Gastrointestinal Disease: Relationship between Erosive Esophagitis and Sarcopenia

• Jung K

• KMID: 2471894
• DOI: http://doi.org/10.4166/kjg.2020.75.3.117

Abstract

No abstract available.

MeSH Terms

Esophagitis*
Gastrointestinal Diseases*
Risk Factors*
Sarcopenia*

Reference

References

1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997; 127(5 Suppl):990S–991S.

2. Miller MD, Crotty M, Giles LC, et al. Corrected arm muscle area: an independent predictor of long-term mortality in commun-ity-dwelling older adults? J Am Geriatr Soc. 2002; 50:1272–1277.

3. Marzetti E, Calvani R, Tosato M, et al. Sarcopenia: an overview. Aging Clin Exp Res. 2017; 29:11–17.

4. Hong S, Choi WH. Clinical and physiopathological mechanism of sarcopenia. Korean J Med. 2012; 83:444–454.

5. Grimby G, Saltin B. The ageing muscle. Clin Physiol. 1983; 3:209–218.

6. Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS). Age Ageing. 2014; 43:748–759.

7. Marty E, Liu Y, Samuel A, Or O, Lane J. A review of sarcopenia: en-hancing awareness of an increasingly prevalent disease. Bone. 2017; 105:276–286.

8. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147:755–763.

9. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002; 50:889–896.

10. Pacifico J, Geerlings MAJ, Reijnierse EM, Phassouliotis C, Lim WK, Maier AB. Prevalence of sarcopenia as a comorbid disease: a systematic review and meta-analysis. Exp Gerontol. 2020; 131:110801.

11. Zhang H, Lin S, Gao T, et al. Association between sarcopenia and metabolic syndrome in middle-aged and older non-obese adults: a systematic review and meta-analysis. Nutrients. 2018; 10:E364.

12. Imagama S, Ando K, Kobayashi K, et al. Increase in lumbar ky-phosis and spinal inclination, declining back muscle strength, and sarcopenia are risk factors for onset of GERD: a 5-year prospective longitudinal cohort study. Eur Spine J. 2019; 28:2619–2628.

13. Heo CM, Kim TJ, Lee H, et al. Impact of sarcopenia on the risk of erosive esophagitis. Korean J Gastroenterol. 2020; 75:132–140.

14. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care. 2012; 15:12–22.

15. Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008; 18:388–395.

16. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011; 29:415–445.

17. Kim TN, Park MS, Ryu JY, et al. Impact of visceral fat on skeletal muscle mass and vice versa in a prospective cohort study: the Korean Sarcopenic Obesity Study (KSOS). PLoS One. 2014; 9:e115407.

18. Petermann-Rocha F, Chen M, Gray SR, Ho FK, Pell JP, Celis- Morales C. New versus old guidelines for sarcopenia classification: What is the impact on prevalence and health outcomes? Age Ageing. 2020; 49:300–304.